Abstract:Background: The migration of peripheral immune cells and splenocytes to the ischemic brain is one of the major causes of delayed neuroinflammation after permanent large vessel stroke. Other groups have demonstrated that leukemia inhibitory factor (LIF), a cytokine that promotes neural cell survival through upregulation of antioxidant enzymes, promotes an anti-inflammatory phenotype in several types of immune cells. The goal of this study was to determine whether LIF treatment modulates the peripheral immune response after stroke. Methods: Young male (3 month) Sprague-Dawley rats underwent sham surgery or permanent middle cerebral artery occlusion (MCAO). Animals were administered LIF (125 μg/kg) or PBS at 6, 24, and 48 h prior to euthanization at 72 h. Bone marrow-derived macrophages were treated with LIF (20 ng/ml) or PBS after stimulation with interferon gamma + LPS. Western blot was used to measure protein levels of CD11b, IL-12, interferon inducible protein-10, CD3, and the LIF receptor in spleen and brain tissue. ELISA was used to measure IL-10, IL-12, and interferon gamma. Isolectin was used to label activated immune cells in brain tissue sections. Statistical analysis was performed using one-way ANOVA and Student's t test. A Kruskal-Wallis test followed by Bonferroni-corrected Mann-Whitney tests was performed if data did not pass the D'Agostino-Pearson normality test. Results: LIF-treated rats showed significantly lower levels of the LIF receptor and interferon gamma in the spleen and CD11b levels in the brain compared to their PBS-treated counterparts. Fluorescence from isolectin-binding immune cells was more prominent in the ipsilateral cortex and striatum after PBS treatment compared to LIF treatment. MCAO + LIF significantly decreased splenic levels of CD11b and CD3 compared to sham surgery. MCAO + PBS treatment significantly elevated splenic levels of interferon inducible protein-10 at 72 h after MCAO, while LIF treatment after MCAO returned interferon inducible protein 10 to sham levels. LIF administration with interferon gamma + LPS significantly reduced the IL-12/IL-10 production ratio compared to macrophages treated with interferon gamma + LPS alone. Conclusions: These data demonstrate that LIF promotes anti-inflammatory signaling through alterations of the IL-12/interferon gamma/interferon inducible protein 10 pathway.

Leukemia Inhibitory Factor Contributes to Reactive Astrogliosis Via Activation of Signal Transducer and Activator of Transcription 3 Signaling after Intracerebral Hemorrhage in Rats.

Leukemia Inhibitory Factor Decreases Neurogenesis and Angiogenesis in a Rat Model of Intracerebral Hemorrhage

Activation of the Notch-1 Signaling Pathway May Be Involved in Intracerebral Hemorrhage-Induced Reactive Astrogliosis in Rats.

Leukemia inhibitory factor modulates the peripheral immune response in a rat model of emergent large vessel occlusion

TLR3 Ligand Poly IC Attenuates Reactive Astrogliosis and Improves Recovery of Rats after Focal Cerebral Ischemia

The Pivotal Role of the NLRC4 Inflammasome in Neuroinflammation after Intracerebral Hemorrhage in Rats

Neuronal pyroptosis mediated by STAT3 in early brain injury after subarachnoid hemorrhage

The protective effect of astrocyte inhibitor fluorocitrate on subarachnoid hemorrhage in rats

VSIG4 Attenuates NLRP3 and Ameliorates Neuroinflammation via JAK2-STAT3-A20 Pathway after Intracerebral Hemorrhage in Mice

The Kinase Inhibitory Region of SOCS3 Attenuates Reactive Astrogliosis and Astroglial Scar in Mice after Traumatic Brain Injury.

Leptin Promotes Angiogenesis via Pericyte STAT3 Pathway upon Intracerebral Hemorrhage

Intracerebral Hemorrhage-Induced Brain Injury: the Role of Lysosomal-Associated Transmembrane Protein 5

LncRNA Snhg3 Contributes to Dysfunction of Cerebral Microvascular Cells in Intracerebral Hemorrhage Rats by Activating the TWEAK/Fn14/STAT3 Pathway.

Inhibition of LAR attenuates neuroinflammation through RhoA/IRS-1/Akt signaling pathway after intracerebral hemorrhage in mice

Activation of the High-Mobility Group Box 1 Protein-Receptor for Advanced Glycation End-Products Signaling Pathway in Rats During Neurogenesis after Intracerebral Hemorrhage

VEGFD/VEGFR3 signaling contributes to the dysfunction of the astrocyte IL-3/microglia IL-3Rα cross-talk and drives neuroinflammation in mouse ischemic stroke

Blockade of High Mobility Group Box-1 Signaling Via the Receptor for Advanced Glycation End-Products Ameliorates Inflammatory Damage after Acute Intracerebral Hemorrhage

Low-intensity Focused Ultrasound Stimulation Promotes Stroke Recovery Via Astrocytic HMGB1 and CAMK2N1 in Mice

Leukemia inhibitor factor promotes functional recovery and oligodendrocyte survival in rat models of focal ischemia

Interleukin-33 Reduces Neuronal Damage and White Matter Injury Via Selective Microglia M2 Polarization after Intracerebral Hemorrhage in Rats.

Hypoxia-Inducible Factor-1 Alpha Accumulation in the Brain after Experimental Intracerebral Hemorrhage